Event: World Drug Safety Congress

October 20-21, 2021 | Boston, MA

Events
Category:
Published on:
October 13, 2021

The World Drug Safety Congress Americas will bring together 600+ top leaders and stakeholders in biopharma to discuss the key challenges they are facing in pharmacovigilance and device safety.

Explore strategies in data management & signal detection, showcase how AI & machine learning have improved PV processes, discuss the challenges creating a PV strategy for advanced therapies, and collaborate on medical device safety strategies.

This conference is the largest commercial gathering of PV professionals in the world.

Who is attending?

Chris Rao

Vice President, Clinical Development

Kenny Carberry

Associate Director, Clinical Development

Christine Peckman 

Director, Pharmacovigilance

Related news

Publications February 2, 2023
Outlook 2023: Firms Prepare For ‘World Where Health Care Has No Limits’
In the latest publication by Medtech Insights by Pharma Intelligence, executives at top device companies and other stakeholders share their expectations.
MedTech Pharma
Publications January 20, 2023
Insights on Market Access
To get her perspective on market access and what to expect in 2023, we spoke with Nerea Blanqué, Senior Vice President of Market Access and Pricing at Alira Health.
Market Access Medical Devices Pharma
Publications January 18, 2023
The State of Biopharma Funding
We spoke with Joris Pezzini, Executive Vice President of Biopharma, Alira Health, during the J.P. Morgan Healthcare Conference in San Francisco, which brings together investors and(...)
Biopharma Biotech Funding Pharma
Publications December 21, 2022
2022 Recap: Your Favorite Alira Health Publications
In 2022, the Alira Health team of scientists, strategists, economists, clinicians, and biostatisticians shared actionable insights, industry thought leadership, and leading-edge guidance(...)
Clinical Digital Health Market Access MedTech Pharma Regulatory
Publications November 8, 2022
Debate sobre los IPT en oncología: buscando puntos de mejora en la evaluación y acceso de los fármacos oncológicos en España
For our Spanish community members, we are glad to share the Debate on IPT in oncology: Looking for points of improvement in the evaluation and access of oncological drugs in Spain.
Oncology Pharma Spain
News October 4, 2022
Alira Health enhances its market access services through a strategic partnership with Centivis
Alira Health, a global healthcare advisory and technology company, announced a strategic partnership with Centivis AG, a boutique market access consulting agency, specializing in digital(...)
Digital Health Market Access MedTech Pharma Regulatory
News September 6, 2022
Alira Health Expands North American Capabilities with the Acquisition of Artisan Healthcare Consulting
The acquisition of Artisan strengthens and extends Alira Health’s Market Access and Management Consulting advisory practices in North America and globally.
Biotech Market Access Pharma Therapeutics
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.